Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference28 articles.
1. Overview of non-Hodgkin’s lymphoma;Fisher;Semin Oncol,2003
2. New treatment approaches to indolent NHL;Seymour;Semin Oncol,2004
3. Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma;Dillman;J Clin Oncol,2002
4. Rituximab and other emerging antibodies as molecular target-based therapy of lymphoma;Tobinai;Int J Clin Oncol,2003
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphomas;McLaughlin;J Clin Oncol,1998
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review;Clinical and Translational Imaging;2019-06
2. Resistance to Y-90 Ibritumomab Tiuxetan Therapy;Resistance to Targeted Anti-Cancer Therapeutics;2018
3. Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma;Therapeutic Advances in Hematology;2017-02-01
4. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response;Critical Reviews in Oncology/Hematology;2016-11
5. Does tumoral 111In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing 90Y-ibritumomab radioimmunotherapy?;European Radiology;2014-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3